Background: Human neuroimaging studies indicate that the amygdala plays a key role in cocaine addiction. One key plasticity factor that modulates effects of cocaine on the brain is Brain-Derived Neurotrophic Factor (BDNF). A wealth of evidence shows that cocaine exposure alters BDNF signaling in corticolimbic structures, but, surprisingly, such evidence is very limited for the amygdala. Additionally, while BDNF is strongly regulated by serotonin levels and inherited serotonin transporter down-regulation is associated with increased vulnerability to cocaine addiction, the effects of serotonin transporter genotype on BDNF signaling in the amygdala under naïve and cocaine exposure conditions are unknown. Methods: We measured BDNF signaling in the central amygdala of wild-type and serotonin transporter knockout rats 24 h into withdrawal from long-access cocaine self-administration. Results: In wild-type rats mature BDNF (mBDNF) protein levels were decreased, whereas the phosphorylation of its receptor TrkB as well as of its intracellular signaling molecules Akt and ERK1 were increased. mBDNF protein expression and its signaling in cocaine-naïve serotonin transporter knockout rats resembled that of wild-type rats with a history of long-access cocaine self-administration. Interestingly, cocaine-exposed serotonin transporter knockout rats showed increased BDNF levels, with no signs of phospho-TrkB receptor coupling to phospho-Akt and phospho-ERK1. Conclusions: Long-access cocaine self-administration dysregulates BDNF signaling in the central amygdala. Vulnerability to cocaine addiction is associated with dysregulation of this signaling.
Introduction
It has been suggested that compulsive use of drugs of abuse is, at least in part, mediated by structural and functional changes in the amygdala, an area that signals negative emotional states (Koob and Le Moal, 2008b) . This is supported by several lines of evidence in humans. For instance, amygdala volume is reduced in cocaine addicts (Makris et al., 2004 ; but see Mei et al., 2015) , amygdala-striatum connectivity is increased in cocaine addicts in response to losing outcomes (Worhunsky et al., 2017) and cocaine users show amygdala hyperresponsiveness during fear conditioning and in response to angry and fearful facial expressions (Crunelle et al., 2015; Kaag et al., 2016) . Preclinical evidence also supports the role of amygdala in cocaine addiction. As such, MRI studies have revealed that, among a few other regions, amygdala exhibits an increased clustering coefficient during the first day of abstinence from cocaine self-administration (Orsini et al., 2018) . In addition, amygdala volume changes correlate with the inability to refrain from cocaine seeking and taking behaviour (Cannella et al., 2014) . Taken together, both preclinical and clinical studies suggest that the amygdala undergoes plasticity changes during cocaine use, but the precise nature of such changes remains to be elucidated.
The neurotrophin Brain-Derived Neurotrophic Factor (BDNF) plays a critical role in brain plasticity, in experimental models of addictive disorders Fumagalli et al., 2013; Li and Wolf, 2015; Verheij et al., 2016) and in corresponding human situations (Castrén and Kojima, 2017; Ornell et al., 2018) . While studies on BDNF in cocaine addiction merely focussed on the prefrontal cortex (Li et al., 2018; McGinty et al., 2010) , nucleus accumbens (Caputi et al., 2019) and ventral tegmental area (Wang et al., 2016; Schmidt et al., 2012) , insight in the role of BDNF in amygdala in relation to cocaine addiction is surprisingly limited. Thus far, it has been reported that a decrease in Bdnf mRNA levels in the amygdala, induced through a virally-mediated approach, impaired cocaine-induced conditioned place preference (Heldt et al., 2014) . Furthermore, during withdrawal from cocaine selfadminstration, time-dependent increase in Bdnf levels in the amygdala were found related to incubation of craving (Grimm et al., 2003) .
Besides BDNF, serotonin plays a key role in neuronal plasticity and cocaine addiction (for review: Müller and Homberg, 2015) . It is known that antidepressant serotonin reuptake inhibitors upregulate BDNF levels, positively influencing neuronal plasticity (Dias et al., 2003; Molteni et al., 2006) . For instance, human studies have shown that the plasmalemmal serotonin transporter (SERT), which regulates the extracellular levels of serotonin, is associated with cocaine addiction (Ersche et al., 2008; Gerra et al., 2007) . In line, we previously found that serotonin transporter knockout (SERT −/− ) rats show increased cocaine self-administration. This was specifically observed under longaccess (LgA) conditions Verheij et al., 2018) , a condition modeling compulsive drug intake (Ahmed and Koob, 1998; Koob and Volkow, 2010) . These rats also display an increased motivation to work for cocaine, and a reduced extinction of cocaine seeking behaviour when cocaine is no longer available (Homberg et al., 2008; Karel et al., 2018) . It is interesting to note that increased LgA cocaine self-administration was found to be associated with changes in the expression of corticotropin releasing factor (CRF) in the central amygdala , a subarea of the amygdala that modulates the negative emotional state observed during withdrawal from cocaine (for review: Koob and Le Moal, 2008b; a; Koob and Volkow, 2010) . It has been shown that CRF is required for stress-induced BDNF release (Walsh et al., 2014) . We suggest that, similar to an increase of CRF, BDNF up-regulation in the central amygdala may enhance the negative emotional state in SERT KO rats, contributing to enhanced escalation. The involvement of the amygdala in the increased cocaine self-administration in SERT −/− rats is supported by the observation that amygdala volume was reduced in SERT -/rats after a history of LgA cocaine self-administration (Karel et al., 2019) . Since there is a bi-directional interaction between serotonin and BDNF (Homberg et al., 2014) , it is plausible that BDNF signaling in the (central) amygdala contributes to the increased cocaine intake in SERT −/− rats.
The aim of this study was to clarify changes in BDNF signaling in the central amygdala in association with compulsive cocaine self-administration, and how these changes are affected by SERT knockout. To this end, wild-type (SERT +/+ ) and SERT −/− rats were allowed to self-administer cocaine under LgA conditions. Twenty-four (24) hours into withdrawal from LgA cocaine self-administration, i.e., at the time point the next self-administration session would start, we sacrificed the animals. Additionally, we included a naïve control group. In the postmortem central amygdala of these rats we evaluated the levels of BDNF, its high affinity receptor TrkB, as well as BDNF-induced major intracellular signaling pathways, i.e., MAP kinase and Akt. Furthermore, given the role of serotonin and BDNF in the regulation of brain remodeling (Brivio et al., 2019; Leal et al., 2014) , we measured Arc/ Arg3.1 and PSD95 as markers of structural integrity (Caffino et al., 2017; Fumagalli et al., 2006) .
Material and methods

Behavior
Animals
SERT −/− rats (SLC6A41Hubr) were generated as previously reported (Smits et al., 2006) and outcrossed with commercially available Wistar rats (Harlan, Ter Horst, the Netherlands) for at least ten generations (Homberg et al., 2008) . Male SERT -/and wild-type (SERT +/+ ) rats, weighing 250-300 g at the beginning of the study, were equipped with jugular vein catheters and subjected to cocaine-self-administration according to the procedures described below (SERT +/+ : n = 12, SERT -/-: n = 14). All rats were housed in groups of 2-3 in Macrolon type III cages (42 × 26 x 15 cm) under a 12 h/12 h reversed day/night cycle (lights off at 8:00 AM) in a temperature-controlled room (22 ± 2°C). Food pellets and water were available ad libitum, except during the cocaine-self-administration sessions. All procedures were carried out in agreement with the current National Research Council Guide for the Care and Use of Laboratory Animals and were approved by local Institutional Animal Care and Use Committees. All efforts were made to reduce the number of animals used and their suffering.
Drug
Cocaine (NIDA, Rockville, MD) was dissolved in saline 0.9%.
Operant testing
Cocaine self-administration was performed in standard operant chambers (28 × 26 x 20 cm, Med Associates Inc., St Albans, VT) placed in a ventilated, light-and sound-attenuating cubicle. Chambers were equipped with a swivel system allowing rats to move freely during cocaine self-administration sessions. Cocaine was delivered by a 15 r.p.m. syringe pump (Razel Scientific Instruments, Georgia, VT). The start of a session was signaled by the presentation of 2 retractable levers into the self-administration chamber. Pressing the right lever delivered cocaine (volume: 0.1 mL in 4 s) whereas pressing the left lever had no programmed consequences. During drug self-administration, a stimulus light above the active lever was illuminated and illumination lasted throughout a time-out period of 40 s, during which operant responding was not reinforced. One week after surgery, rats were trained to self-administer cocaine (0.5 mg/kg/infusion) under a fixed ratio 1 (FR1) schedule of reinforcement for 10 days for 1 h/day. Two days after cocaine self-administration training, rats were allowed to self-administer cocaine during daily 6 h sessions (extended or Long-Access (LgA) group of rats), for a total of 15 days (Ahmed and Koob, 1998) . For both training and LgA cocaine self-administration there was no maximum set for the number of infusions. After each infusion there was a time out for 40 s to prevent overdosing.
Additional groups of cocaine-naive SERT −/− (n = 8) and SERT +/+ (n = 6) rats also underwent intravenous catheterization, were handled daily, and received daily infusions of heparinized saline, but were not exposed to the self-administration chambers and the discrete cues that predict cocaine availability (Verheij et al., 2016 .
Molecular analyses
Collection of central amygdala tissue
Twenty-four hours following the last cocaine self-administration session, a randomized part of the rats that had self-administered cocaine (n = 6-8) was sacrificed by decapitation. The control animals were also decapitated. After decapitation brains were quickly collected and stored at -80 0 C. According to the rat brain atlas of Paxinos and Watson (2007), a 1 mm diameter region containing bilateral central amygdala was punched (coordinates between bregma -1.72 mm and bregma -3.48 mm) from frozen dissected brain sections of 220 μm . Central amygdala tissue was stored at −80°C until being processed for molecular analysis (see below). Material of one hemisphere was used for RNA isolation, and material of the other hemisphere for protein analysis.
RNA preparation and real-time polymerase chain reaction
Total RNA of 6-8 randomly selected rats/genotype/treatment was isolated by single step guanidinium isothiocyanate/phenol extraction using PureZol RNA isolation reagent (Bio-Rad Laboratories, Segrate, Milan, Italy) according to the manufacturer's instructions and quantified by spectrophotometric analysis. Following total RNA extraction, the samples were processed for real-time reverse transcription L. Caffino, et al. Drug and Alcohol Dependence 205 (2019) 107610 polymerase chain reaction (real time RT-PCR) to assess mRNA levels, as previously described (Caffino et al., 2015) . Briefly, an aliquot of each sample was treated with DNase to avoid DNA contamination. RNA was analyzed by TaqMan qRT-PCR instrument (CFX384 real time system, Bio-Rad Laboratories) using the iScriptTM one-step RT-PCR kit for probes (Bio-Rad Laboratories). Samples were run in 384 wells formats in triplicate as multiplexed reactions. Thermal cycling was initiated with an incubation at 50°C for 10 min (RNA retrotranscription) and then at 95°C for 5 min (TaqMan polymerase activation). After this initial step, 39 cycles of PCR were performed. Each PCR cycle consisted of heating the samples at 95°C for 10 s to enable the melting process and then for 30 s at 60°C for the annealing and extension reaction. Data were analyzed with the comparative threshold cycle (□□Ct) method using either 36B4 or □-actin as reference genes. The primer efficiencies were experimentally set up for each couple of primers. Primers and probe for Bdnf exon IV and VI were purchased from Applied Biosystem (BDNF exon IV: ID Rn01484927_m1 and Bdnf exon VI: ID Rn01484928_m1). Primers and probe for total Bdnf, Bdnf exon I and 36B4 were purchased from Eurofins MWG-Operon. Their sequences are shown below:
-total Bdnf: forward primer 5′-AAGTCTGCATTACATTCCTCGA-3′, reverse primer 5′-GTTTTCTGAAAGAGGGACAGTTTAT-3′, probe 5′-TGTGGTTTGTTGCCGTTGCCAAG-3′; -Bdnf exon I: forward primer 5′-GGGAGACGAGATTTTAAGACA CTG-3′, reverse primer 5′-GTCATCACTCTTCTCACCTGG-3′, probe 5′-TTGTGGCTTTGCTGTCCTGGAGA-3′; -36B4: forward primer 5′-TTCCCACTGGCTGAAAAGGT-3′, reverse primer 5′-CGCAGCCGCAAATGC-3′, probe 5′-AAGGCCTTCCTGGCC GATCCATC-3′.
Protein extraction and western blot analyses
Central amygdala tissues of 6 randomly selected rats/genotype/ treatment randomly selected animals were homogenized in a glass-glass potter using a cold buffer containing 0.32 M sucrose, 1 mM Hepes solution, 0.1 mM EGTA, 0.1 mM PMSF, pH = 7.4, in presence of a complete set of protease inhibitors and a phosphatase inhibitor cocktail. Total proteins have been measured in the whole homogenate by the Bio-Rad Protein Assay (Bio-Rad Laboratories). Western blots were run as previously described . Briefly, fifteen micrograms of proteins for each sample were run under reducing conditions on the criterion TGX precast gels (Bio-Rad Laboratories, Milan, Italy) under reducing conditions and then electrophoretically transferred onto nitrocellulose membranes (GE Healthcare, Milan, Italy). Blots were blocked 1 h at room temperature with 10% non-fat dry milk in tris buffered saline + 0.1% Tween-20 buffer and then incubated with antibodies against the total proteins of interest.
The conditions of the primary antibodies were the following: anti mBDNF (1:1000, Icosagen, USA); anti phospho-TrkB Tyr816 (1:1000, Cell Signaling Technology, USA), anti phospho-TrkB Tyr706 (1:500, Cell Signaling Technology, USA), anti phospho-Akt Ser473 (1:1000, Cell Signaling Technology, USA), anti phospho-ERK1 Thr202/Tyr204 and phospho-ERK2 Thr185/Tyr187 (1:1000, Cell Signaling Technology, USA), anti-total TrkB (1:500, Cell Signaling Technology, USA), Akt (1:1000, Cell Signaling Technology, USA), ERK2 (1:5000, Cell Signaling Technology), anti PSD95 (1:4000, Cell Signaling Technology, USA), Arc/Arg3.1 (1:500, BD Transduction Laboratories, USA) and anti βactin (1:10,000, Sigma-Aldrich). Results were standardized to β-actin control protein, which was detected by evaluating the band density at 43 kDa. Immunocomplexes were visualized by chemiluminescence using the Chemidoc MP Imaging System (Bio-Rad Laboratories). Activation of the proteins investigated were expressed as a ratio between the phosphorylated and the respective total forms and analyzed using the Image Lab software from Bio-Rad Laboratories.
Statistical analysis
Data were collected in individual animals (independent determinations) and are presented as means ± standard errors. The effects of genotype on cocaine self-administration were analyzed using a two-way analysis of variance (ANOVA) with a correction for repeated measures followed by a Student's t-test
To enable visual comparisons across genotypes with different degrees of expression of BDNF and its signaling pathways, values are presented as percent of the control group, namely the SERT +/+ -naive group that was not exposed to LgA cocaine self-administration. Molecular changes produced by genotype and cocaine exposure alone as well as by their combination were analyzed using a two-way ANOVA, with genotype and cocaine self-administration as independent variables. When dictated by relevant interaction terms, Bonferroni multiple comparisons test was used to characterize differences among individual groups of rats. When no interaction between genotype and cocaine selfadministration was observed, only the main effects were reported. Significance for all tests was assumed at p < 0.05.
Results
Cocaine intake
During the acquisition of cocaine self-administration, no genotype differences were observed (Fig. 1A) . When the rats were allowed to selfadminister cocaine under long access conditions, the daily number of cocaine-reinforced lever presses was higher in SERT −/− versus SERT +/ + rats (Fig. 1B : genotype x session effect: F (14,336) = 1.797, p = 0.038), with a higher total cocaine intake in SERT −/− (1204 +/-84 infusions) versus SERT +/+ (832 +/-157 infusions) rats (t-test: p = 0.020). The number of inactive lever presses was similar in both genotypes (Fig. 1C) . 
Molecular analyses
Molecular analyses were performed on the central amygdala from rats sacrificed 24 h following the last cocaine self-administration session. We first analyzed total Bdnf mRNA levels in SERT −/− and SERT +/ + rats, with and without LgA cocaine self-administration. Fig. 2 shows that SERT knockout modulated the neurotrophin expression in both cocaine-naïve and LgA cocaine-exposed rats. Two-way ANOVA of total Bdnf revealed a significant effect of treatment (F (1,22) = 9.563, p = 0.0053), genotype (F (1,22) = 6.324, p = 0.0197) and a significant genotype x treatment interaction effect (F (1,22) = 5.822, p = 0.0246). Examining the individual treatment effect, we found that LgA cocaine self-administration increased Bdnf mRNA levels only in SERT −/− rats (+43% vs SERT −/− -naïve rats, p = 0.0063; +39% vs SERT +/+ -LgA rats, p = 0.0164; Fig. 2A) .
Given the complexity of the Bdnf gene, consisting of different isoforms driven by separate promoters (Aid et al., 2007) , and taking into account that such isoforms may respond to different stimuli and be differently located in neurons, we expanded our analysis by investigating exon I, exon IV and exon VI Bdnf mRNA levels. Analysis of exon I revealed a significant effect of treatment (F (1,22) = 37.23, p < 0.0001) and a genotype x treatment interaction effect (F (1,22) = 18.00, p = 0.0003). Compared to naïve SERT +/+ rats, basal levels of Bdnf exon I were reduced in SERT −/− rats (-34% vs SERT +/ + -naïve rats, p = 0.0252). Additionally, similar to the pattern seen for total Bdnf, cocaine self-administration was associated with up-regulated Bdnf exon I gene expression in SERT −/− rats (+81% vs SERT −/− -naïve rats, p < 0.0001; Fig. 2B ). We then analyzed exon IV expression levels, the most abundant activity-dependent transcription factor. We found an effect of genotype (F (1,22) = 17.56, p = 0.0004) and treatment (F (1,22) = 16.62, p = 0.0005), and a genotype x treatment interaction effect (F (1,22) = 5.211, p = 0.0325; Fig. 2C ). In particular, LgA cocaine self-administration was associated with a marked increase in Bdnf exon IV levels only in SERT −/− rats (+75% vs SERT −/− -naïve rats, p = 0.0015; +77% vs SERT +/+ -LgA cocaine self-administration rats, p = 0.0013). Finally, we examined the expression of Bdnf exon VI, located in dendrites (Chiaruttini et al., 2008) , a feature that allows its prompt synthesis in case of demand. Two-way ANOVA of Bdnf exon VI revealed an effect of treatment (F (1,22) = 8.644, p = 0.0076), no effect of genotype (F (1,22) = 5.629, p = 0.0268) and a genotype x treatment interaction effect (F (1,22) = 6.997, p = 0.0148). Post-hoc testing indicated a marked and significant increase of Bdnf exon VI in the central amygdala of cocaine exposed SERT −/− rats compared to SERT −/− naïve rats (+78%, p = 0.0056) and SERT +/+ rats with a history of LgA cocaine self-administration (+70%, p = 0.0142) (Fig. 2D) .
We then analyzed protein expression of the mature form of BDNF (mBDNF) in the central amygdala of SERT −/− and wild-type rats, with and without LgA cocaine self-administration (Fig. 3A) . Two-way ANOVA of mBDNF expression revealed a significant genotype x treatment interaction effect (F (1,22) = 34.24, p < 0.0001). In particular, SERT deletion evoked a significant decrease in mBDNF protein levels in cocaine naïve rats (-26% vs SERT +/+ -naïve rats, p = 0.0205). Interestingly, LgA cocaine self-administration was associated with a decrease in mBDNF levels in SERT +/+ rats (-26% vs SERT +/+ -naïve rats, p = 0.0175) but an increase in SERT -/rats (+41% vs SERT −/− -naïve rats, p = 0.0004; +41% vs SERT +/+ -LgA cocaine self-administration rats, p = 0.0004) (Fig. 3A) .
We next analyzed the expression and phosphorylation of the BDNF receptor TrkB in the central amygdala. Fig. 3B and C shows activation of TrkB in two distinct sites of phosphorylation, i.e., pTrkB (Tyr816) and pTrkB (Y706). No significant effects were found when examining pTrkBY816/TrkB levels. Conversely, two-way ANOVA of pTrkBY706/ L. Caffino, et al. Drug and Alcohol Dependence 205 (2019) 107610 TrkB levels revealed an effect of genotype (F (1,22) = 6.017, p = 0.0226) and treatment (F (1,22) = 9.926, p = 0.0046) as well as a significant genotype x treatment interaction effect (F (1,22) = 5.173, p = 0.033). In wild-type rats, LgA cocaine self-administration was associated with an increased activation of pTrkB (Tyr706) (+84% vs SERT −/− -naïve rats, p = 0.0039). Naïve SERT -/displayed a significant increase in pTrkB (Tyr706) (+73% vs SERT −/− -naïve rats, p = 0.0134), but LgA selfadministration cocaine had no further effect on TrkB phosphorylation (Tyr706) in the central amygdala of SERT -/rats (+14% vs SERT −/ − -naïve rats, p > 0.99).
Next, we investigated whether the changes in the BDNF-TrkB system would translate to the recruitment of BDNF intracellular pathways, as previously shown (Giannotti et al., 2014) . Two-way ANOVA of Akt activation revealed a significant treatment effect (F (1, 22) = 4.834, p = 0.0387), and a genotype x treatment interaction effect (F (1,22) = 4.532, p = 0.0447; Fig. 4A ). In wild-type rats with a history of LgA cocaine self-administration, as well as cocaine-naïve SERT −/− rats, pAktS473/Akt levels were upregulated (+33% SERT −/− -naïve rats vs SERT +/+ -naïve, p = 0.0358; +32% vs SERT +/+ -LgA cocaine self-administration vs SERT +/+ -naïve rats, p = 0.0268), whereas there was no further change in pAktS473/Akt levels after LgA cocaine selfadministration in SERT -/rats (0% vs SERT −/− -naïve rats, p > 0.99).
Two-way ANOVA of pERK1(Thr202/Tyr204)/ERK1 levels revealed an effect of treatment (F (1,22) = 8.201, p = 0.009) and a significant genotype x treatment interaction effect (F (1,22) = 5.538, p = 0.028; Fig. 4B ). In wild-type rats, LgA cocaine self-administration was associated with increased pERK1 levels (+47% vs SERT −/− -naïve rats, p = 0.0056) whereas no changes in pERK1 levels were observed in SERT −/− rats (+2% vs SERT −/− -LgA rats, p > 0.999). Conversely, investigation of ERK2 expression and its phosphorylation (Thr185/ Tyr187) revealed no effect of treatment (F (1,22) = 0.9566, p = 0.3387), genotype (F (1,22) = 1.634, p = 0.2145) and genotype x treatment interaction effect (F (1,22) = 0.163, p = 0.6903; Fig. 4C ).
We finally analyzed the expression of two major structural synaptic proteins, PSD95 and Arc/Arg3.1, to evaluate whether LgA cocaine selfadministration may result in changes in structural or functional integrity of the post-synaptic density (see also : Fumagalli et al., , 2007 Caffino et al., 2017 Caffino et al., , 2015 . With respect to PSD95 (Fig. 5A) , we found an effect of genotype (F (1,20) = 12.59, p = 0.002) and a significant genotype x treatment interaction effect (F (1, 20) = 19.75, p = 0.0002). LgA cocaine self-administration was associated with enhanced PSD95 levels in the central amygdala of wild-type rats (+42% vs SERT +/+ -naïve rats, p = 0.0144), but reduced PSD95 levels in SERT −/− rats (-68% vs SERT +/+ -LgA cocaine self-administration rats, p = 0.0002) (Fig. 5A ). Examining Arc/Arg3.1 expression we found only a significant genotype x treatment interaction effect (F (1,21) = 27.49, p = 0.0001). LgA cocaine self-administration was associated with increased Arc/Arg3.1 levels in the central amygdala of wild-type rats (+43% vs SERT +/+ -naïve rats, p = 0.0222). Furthermore, SERT −/− was associated with an up-regulation of Arc/Arg3.1 protein levels in cocaine-naive SERT −/− rats (+47% vs SERT +/+ -naïve rats, p = 0.0111). Finally, LgA cocaine self-administration was associated with diminished Arc/Arg3.1 expression in SERT −/− rats (-57% vs SERT −/− -naïve rats, p = 0.0028; -53% vs SERT +/+ -LgA cocaine selfadministration rats, p = 0.0056; Fig. 5B ).
Discussion
Our findings show that short-term (24 h) withdrawal from Long-Access (LgA) cocaine self-administration decreases mBDNF protein levels in the central amygdala of SERT +/+ rats. This goes along with increased TrkB (Y706) receptor phosphorylation (indicative of increased activity) and an increase in ERK1-and Akt-dependent intracellular signaling. Additionally, the state of the BDNF system in cocaine-naïve SERT −/− rats resembles that of the BDNF system in cocaine-exposed SERT +/+ rats. Finally, we observed that LgA cocaine self-administration led to an overall dysregulation of BDNF intracellular signaling in the central amygdala of SERT −/− rats (for summary, see Fig. 6 ).
The decreased mBDNF protein levels in cocaine-exposed SERT +/+ rats may reflect a compensatory response to the increased TrkB receptor and Akt-and ERK1-dependent intracellular signaling. Since increased TrkB receptor signaling generally facilitates neuroplasticity (Duman and Voleti, 2012) , our findings could be interpreted as adaptive changes to support homeostasis with high levels of cocaine on board.
Like in cocaine exposed SERT +/+ rats, we found an overall reduction in the expression of BDNF protein in cocaine-naïve SERT −/− rats. This suggests that increased extracellular serotonin negatively affects the synthesis of BDNF, an effect previously seen for the prefrontal cortex and hippocampus (Calabrese et al., 2013; Molteni et al., 2010) . In cocaine-exposed SERT −/− rats, we found that changes in basal Bdnf mRNA levels (total BDNF as well as BDNF exons with the exception of Fig. 4 . Interaction between SERT deletion and cocaine self-administration on BDNF-induced intracellular signaling pathways in the whole homogenate of the central amygdala. Panel a, b and c show the phosphorylation of Akt, ERK1 and ERK2, respectively, expressed as the ratio between the phosphorylated and the total form of the protein. Below the graphs, representative immunoblots are shown for pAkt S473/Akt (60 kDa), pERK1Thr202-Tyr204/ERK1 (44 kDa) and pERK2Thr185-Tyr187/ERK2 (42 kDa) proteins in the homogenate of central amygdala. Histograms, expressed as percentages of SERT +/+ -naive rats, represent the mean ± SEM of eight to six rats per group. *p < 0.05 versus SERT +/+ -naive (two-way ANOVA followed by Bonferroni multiple comparisons test) BDNF exon IV) were paralleled by changes in basal mBDNF protein expression. This association between gene and protein expression is not necessarily expected as we have previously shown (Fumagalli et al., 2007) . The combined Bdnf gene and protein changes indicate that the changes caused by SERT knockout are enduring and stable. Although the functional consequences of multiple Bdnf transcripts are still obscure, specific exons may undergo different subcellular localization (Aid et al., 2007) , which may be functionally relevant. In fact, changes in Bdnf exon I and IV, localizedat somatic level, may be indicative of altered neuronal activity whereas Bdnf exon VI changes may reflect an altered dendritic targeting of this isoform. Following LgA cocaine selfadministration BDNF exons I, IV and VI increased in SERT −/− rats, in line with total BDNF mRNA levels, ruling out the possibility of a cocaine-induced effect on a specific neurotrophin pool (i.e., somatic vs. dendritic). Previous data have shown that, following repeated cocaine self-administration, Bdnf expression is increased in the rat amygdala after 30 and 90, but not 1, day(s) of withdrawal, an effect related to the incubation of craving (Grimm et al., 2003) . Our results suggest that changes in extracellular serotonin induced by SERT deletion may shorten the latency of BDNF elevation, providing a mechanism for the higher cocaine intake in these animals.
TrkB is the high affinity receptor that mediates the action of BDNF by activating its intracellular pathways. Its specific action strictly depends on its phosphorylation sites, whose stimulation addresses the activation of a different BDNF-dependent signaling pathway. Accordingly, we measured two different phosphorylation sites of TrkB, namely pTrkB (Y816), which regulates PLC□-mediated signaling, and pTrkB (Y706), which regulates both ERK and Akt phosphorylation (Minichiello, 2009) . First, we noted that the baseline phosphorylation level is different between the phosphorylation sites, since pTrkB (Y816) is unaltered while pTrkB (Y706) is increased in the central amygdala of cocaine-naïve SERT −/− rats. Accordingly, basal ERK1 and Akt phosphorylation is increased in SERT -/rats, at variance from ERK2 phosphorylation that is unchanged. Thus, these data unravel a previously unappreciated difference between ERK 1 and ERK2 as ERK2 appears to be uncoupled from its related phosphorylation site of TrkB. The role of each of these two isoforms has not been extensively characterized in the amygdala. While being aware that phosphorylation of a given protein may depend upon the presence and expression level of protein phosphatases, these findings suggest separate regulatory mechanisms for Below the graphs, representative immunoblots are shown for PSD95 (95 kDa) and Arc/Arg3.1 (55 kDa) proteins in the homogenate of central amygdala. Histograms, expressed as percentages of SERT +/+ -naive rats, represent the mean ± SEM of eight to six rats per group. *p < 0.05, ## p < 0.01 versus SERT +/+ -naive; # p < 0.05, ### p < 0.001 versus SERT-/-naive; $$ p < 0.01, $$$ p < 0.001 versus SERT +/+ -LgA (two-way ANOVA followed by Bonferroni multiple comparisons test) L. Caffino, et al. Drug and Alcohol Dependence 205 (2019) 107610 ERK1 and ERK2 in the central amygdala. Second, we observed that LgA cocaine self-administration was associated with changes in the phosphorylation level of the 2 pathways in SERT +/+ and SERT −/− rats. Whereas no changes were observed in ERK2 phosphorylation following cocaine exposure in both genotypes, SERT +/+ rats showed a marked increase in ERK1 and Akt phosphorylation. In contrast, the knockout of SERT could not promote a further increase of ERK1 and Akt activation. The cocaine-induced activation of the Akt-mediated pathway in SERT +/+ rats may have functional relevance. In fact, it has been demonstrated that BDNF, through Akt (Yoshii and Constantine-Paton, 2007) , influences dendritic spine formation and stability (Berry et al., 2018; Kim and Sheng, 2004) . The analysis of PSD95, a structural marker of dendritic spines, revealed that the cocaine mediated activation of the BDNF-TrkBY706-Akt pathway in SERT +/+ rats may upregulate PSD95 expression, which is instead reduced in the central amygdala of SERT −/− rats. Notably, we found that the expression of the other BDNF downstream target Arc/Arg3.1, which is engaged in structural synaptic plasticity in the amygdala (You et al., 2014) and regulated by cocaine (Caffino et al., 2017 (Caffino et al., , 2015 , fully overlaps with the PSD95 expression profile. Accordingly, we point to Arc/Arg3.1 and PSD95 as signatures of amygdaloid structural dysregulation following LgA cocaine self-administration in SERT -/rats. These findings suggest that LgA cocaine self-administration alters the physiological structural remodeling as a function of the serotonergic tone likely through, at least partially, the BDNF-TrkB-Akt cascade. As a very big step, the cocaineinduced reduction in PSD95 and Arc/Arg3.1 may contribute to the smaller amygdala volume of cocaine-exposed SERT -/rats (Karel et al., 2019) and cocaine addicts (Makris et al., 2004) . Furthermore, the increase of Bdnf mRNA and protein levels observed in SERT -/rats exposed to LgA cocaine self-administration may reflect an attempt to compensate for the structural alterations shown by the reduced expression of PSD95 and Arc/Arg3.1 in these animals. While we believe that our manuscript shows several strengths, we are also aware that it suffers from some limitations. First, our study does not show whether cocaine intake leads to changes in BDNF, or whether BDNF lead to changes in the intake of cocaine. Second, mBDNF may have affected the phosphorylation of TrkB sites other than Tyr706 or Tyr816. Third, while the amygdala is specifically linked to emotional changes in addiction, we did not measure emotion in this study. From our previous work, however, we know that anxiety is increased in SERT −/− rats, relative to wild-type rats, 24 h into withdrawal from LgA cocaine self-administration . This suggests that the BDNF-Arc/Arg3.1-PSD95 reductions found in SERT -/rats following LgA cocaine self-administration is related to increased anxiety, as previously demonstrated (Moonat et al., 2011) .
In conclusion, we here show that 24 h withdrawal from long-access Fig. 6 . Schematic representation of the changes of BDNF and its associated network set in motion by the combination of SERT knockout and long-access cocaine selfadministration: comparison with between SERT +/+ and SERT −/− rats.
L. Caffino, et al. Drug and Alcohol Dependence 205 (2019) 107610 cocaine self-administration is associated with decreases in mBDNF protein expression levels and increases in TrkB signalling in the central amygdala of wild-type animals. The knockout of SERT increases BDNF protein expression and perturbs TrkB signaling in the central amygdala following long-access cocaine self-administration. This implies that BDNF and serotonin at least partly mediate compulsive cocaine-selfadministration.
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